Frontiers in Immunology publishes peer-reviewed research articles that advance understanding of both fundamental principles and clinical applications of immunology. It will also highlight studies that expand existing knowledge about the underlying mechanisms that drive the immune system to help translate previous findings into better diagnostic and therapeutic approaches.

Frontiers in Immunology

Frontiers in Immunology is a MEDLINE, PubMed Central, Scopus, and Science Citation Index Expanded (SCIE) indexed journal, and serves as the official journal of the International Union of Immunological Societies (IUIS). By providing unrestricted global access to this high-impact journal through its publication model, Frontiers in Immunology gives researchers, physicians, clinicians, and health professionals access to scientifically based evidence of their respective areas of study.

The New England Journal of Medicine (NEJM) is regarded as one of the leading peer-reviewed medical journals in the world. NEJM’s purpose is to advance medical science and improve patient care by publishing articles describing original clinical research, information pertaining to clinical research and reviews, and thought-provoking commentaries on current events impacting healthcare.

NEJM acts as a worldwide dissemination platform for clinical trials, translational research, and evidence-based knowledge that impacts health policy, clinical guidelines, and clinical practice. NEJM publishes papers with very high editorial standards and goes through a rigorous peer-review process, ensuring that all articles published demonstrate scientific excellence and relevance to medical practice. NEJM bridges the gap between scientific discovery and clinical practice and significantly influences healthcare practice and medicine around the world.

Aim and Scope

Frontiers in Immunology publishes peer-reviewed research articles that advance understanding of both fundamental principles and clinical applications of immunology. It will also highlight studies that expand existing knowledge about the underlying mechanisms that drive the immune system to help translate previous findings into better diagnostic and therapeutic approaches.

The journal is open to papers that cover

Advances in biological medicines and immunotherapy.
Development, regulation, and functioning of the immune system.
The molecular basis and clinical manifestations of human immune dysfunction.
Novel diagnostic and therapeutic modalities for immune-mediated illnesses.
Precision medicine in the context of immune diseases.
Investigations using animal models, cellular systems, or human subjects; and systems immunology supported by solid experimental validation.

Frontiers in Immunology welcomes novel, innovative research that responds to global health priorities and promotes sustainable healthcare innovations.

Scope exclusions:

This journal does not except for publication:

Clinical study or medical therapy that does not have a distinct immunological component
Molecular biology study that does not have a relevant immunological application
Computational analysis of publicly available data without an adequate level of experimental validation

All computational studies must adhere to Frontiers’ research methods policy.

Publishing in Frontiers in Immunology demands scientific depth and methodological rigour. Our immunology manuscript editing services refine your study to align with the journal’s translational focus. Whether you are preparing an immune disorder research submission or seeking immunotherapy journal support, we provide targeted assistance to strengthen clarity and impact. From clinical immunology publication services to detailed molecular immunology editing, our team ensures your research meets the journal’s high editorial and peer-review standards.